secwatch.observer — SEC 8-K summary
======================================

Issuer:     CONMED Corp (CNMD)
CIK:        0000816956
Form:       8-K
Filed at:   2024-10-04T23:59:59+00:00
Accession:  0001193125-24-232621
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CONMED prelim Q3 rev $315-318M; adj EPS growth to exceed 9-11% guide
--------------------------------------------------------------------

- Revenue expected $315M-$318M for Q3 2024 (preliminary).
- Adjusted diluted EPS growth exceeds previously guided 9%-11% range.
- Full Q3 results to be reported Oct 30, 2024 after market close.
- Data is preliminary; may change upon completion of financial close.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/816956/000119312524232621/0001193125-24-232621-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/816956/000119312524232621/d117527d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-232621

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer